Barclays has initiated coverage on Healthequity Inc (HQY) with an Overweight rating, marking its first assessment of the company. This decision reflects Barclays' analysis of Healthequity's business model and growth potential in the health care sector.
Headquartered in Draper, Utah, Healthequity provides technology-enabled services for healthcare spending decisions. The company manages consumer tax-advantaged health savings accounts (HSAs) and other benefits, including flexible spending accounts and health reimbursement arrangements. It also administers COBRA and commuter benefits, employing 3,105 full-time staff.
As of December 8, 2025, Healthequity's stock trades at $97.42, with a market capitalization of $7.9 billion. The company has a P/E ratio of 41.02 and reported an EPS of 2.18. Upcoming earnings are anticipated on March 16, 2026, with an estimated EPS of $0.91 and revenue of $335.7 million.
Analyst consensus indicates a Buy rating, with 7 Strong Buy, 9 Buy, and 3 Hold ratings among 19 analysts. The recent action by Barclays underscores the firm's commitment to evaluating Healthequity's performance in a dynamic market.